Takeda Pharmaceuticals International AG's Net Worth
$139 Million
Who is Takeda Pharmaceuticals International AG?
Takeda Pharmaceuticals International AG has an estimated net worth of $139 Million. This is based on reported shares across multiple companies, which include Cortexyme, Inc., Molecular Templates, Inc., and Myovant Sciences Ltd..
SEC CIK
Takeda Pharmaceuticals International AG's CIK is 0001688140
Past Insider Trading and Trends
2017 was Takeda Pharmaceuticals International AG's most active year for acquiring shares with 4 total transactions. Takeda Pharmaceuticals International AG's most active month to acquire stocks was the month of December. 2017 was Takeda Pharmaceuticals International AG's most active year for disposing of shares, totalling 4 transactions. Takeda Pharmaceuticals International AG's most active month to dispose stocks was the month of February. 2016 saw Takeda Pharmaceuticals International AG paying a total of $0.00 for 1,999,410 shares, this is the most they've acquired in one year. In 2018 Takeda Pharmaceuticals International AG cashed out on 7,420,625 shares for a total of $138,543,068.75, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Cortexyme, Inc. (QNCX) Snapshot price: $0.71
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.68M |
—
|
—
| 2.68M |
May 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Molecular Templates, Inc. (MTEM) Snapshot price: $1.53
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Myovant Sciences Ltd. No price found
InvestorTakeda Pharmaceuticals International AG owns 7,420,625 units of Common Shares. Takeda Pharmaceuticals International AG used to own units in Common Stock but no longer holds any shares there. From 2016 to 2018 Takeda Pharmaceuticals International AG acquired a total of 2,029,505 shares in Myovant Sciences Ltd., Takeda also disposed a total of 7,420,625 shares of Myovant Sciences Ltd. equalling to $138,543,068.75.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$18.67 |
—
| 7.42M |
Mar 19
| |||
Form 4
| +0.06% | 4.43K |
—
|
—
| 7.42M |
Apr 17
| |||
Form 4
| +0.27% | 19.94K |
—
|
—
| 7.42M |
Feb 15 - Mar 15
| |||
Form 4
| +0.38% | 27.87K |
—
|
—
| 7.4M |
Dec 15 - Jan 17
| |||
Form 4
| +36.68% | 1.98M |
—
|
—
| 7.37M |
Nov 1
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |